(9-403) Comparing Efficacy Between Rituximab Biosimiliars and Rituximab Reference Product in Treating Aggressive B-cell Lymphomas: Non-Interiority, Retrospective Cohort Study

Wednesday, December 7, 2022

8:30 AM – 9:30 AM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Oncology/Hematology

Co-Author(s): Robert Wilkinson, Jose Sandoval-Sus

Primary Author(s)

Ashley Dabalsa, PharmD, MBA
PGY-1 Pharmacy Resident
Memorial Hospital West, Florida